Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

Clinical trial NCT05579899 · COMPLETED

Trial details

NCT number: NCT05579899
Sponsor: Evommune, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis Eczema

Start date: 2022-09-27
Primary completion: 2023-07-27
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.